Advertisement

Effects of Hyaluronic Acid With Intra-articular Corticosteroid Injections in the Management of Subtalar Post-traumatic Osteoarthritis – Randomized Comparative Trial

Published:March 12, 2022DOI:https://doi.org/10.1053/j.jfas.2022.03.003

      Abstract

      We investigated the potential of exogenous hyaluronic acid (HA) associated with corticosteroid injections to improve pain and function for the treatment of post-traumatic subtalar osteoarthritis, in comparison with isolated intra-articular corticosteroid. Twenty-five symptomatic participants (50 ± 8 years) with a minimum follow-up of 1 year after surgery for calcaneus fractures were enrolled. Participants were randomly assigned into a therapeutic group that underwent isolated corticosteroid intra-articular subtalar injection (Corticosteroid Group, n = 12) or a combination of HA plus corticosteroid (HA+C Group, n = 13). All participants underwent three repeated injections with intervals of 1 week. We assessed the visual analog scale of pain (VAS) and the AOFAS scores at 4 moments: before treatment (pre), 4-, 12-, and 24-weeks following the last injection. HA+C Group showed lower VAS at the 12th (p = .003) and 24th weeks (p = .003) and greater AOFAS at the 4th (p = 0.040), 12th (p = .014), and 24th weeks (p = .021), in comparison to Corticosteroid Group. We observed a reduction in VAS in the Corticosteroid Group only at the 4th week (p = .007), compared with pretreatment values. In the HA+C Group, VAS presented lower levels at the 4- (p < .001), 12- (p < .001), and 24 weeks (p < .001). In the Corticosteroid Group, participants presented higher AOFAS score only at the 4th week (p < .001), while in the HA+C Group, the AOFAS scores were greater at the 4th, 12th, and 24th weeks compared to baseline (p < .001). The combination of exogenous HA and corticosteroid showed greater and longer analgesic effects and function improvement in comparison with isolated intra-articular corticosteroids.

      Level of Clinical Evidence

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Foot and Ankle Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sanders R.
        Displaced intra-articular fractures of the calcaneus.
        J Bone Joint Surg Am. 2000; 82: 225-250
        • Sharr PJ
        • Mangupli MM
        • Winson IG
        • Buckley RE.
        Current management options for displaced intra-articular calcaneal fractures: Non-operative, ORIF, minimally invasive reduction and fixation or primary ORIF and subtalar arthrodesis. A contemporary review.
        Foot Ankle Surg. 2016; 22: 1-8
        • Mitchell MJ
        • McKinley JC
        • Robinson CM.
        The epidemiology of calcaneal fractures.
        Foot (Edinb). 2009; 19: 197-200
        • SooHoo NF
        • Farng E
        • Krenek L
        • Zingmond DS.
        Complication rates following operative treatment of calcaneus fractures.
        Foot Ankle Surg. 2011; 17: 233-238
        • Lim EV
        • Leung JP.
        Complications of intraarticular calcaneal fractures.
        Clin Orthop Relat Res. 2001; : 7-16
        • Radnay CS
        • Clare MP
        • Sanders RW.
        Subtalar fusion after displaced intra-articular calcaneal fractures: does initial operative treatment matter?.
        J Bone Joint Surg Am. 2009; 91: 541-546
        • Csizy M
        • Buckley R
        • Tough S
        • Leighton R
        • Smith J
        • McCormack R
        • Pate G
        • Petrie D
        • Galpin R.
        Displaced intra-articular calcaneal fractures: variables predicting late subtalar fusion.
        J Orthop Trauma. 2003; 17: 106-112
        • Zwipp H
        • Rammelt S
        • Barthel S.
        Calcaneal fractures–open reduction and internal fixation (ORIF).
        Injury. 2004; 35 (SB46-54)
        • Russotti GM
        • Cass JR
        • Johnson KA.
        Isolated talocalcaneal arthrodesis. A technique using moldable bone graft.
        J Bone Joint Surg Am. 1988; 70: 1472-1478
        • Mann RA
        • Baumgarten M.
        Subtalar fusion for isolated subtalar disorders. Preliminary report.
        Clin Orthop Relat Res. 1988; : 260-265
        • Joveniaux P
        • Harisboure A
        • Ohl X
        • Dehoux E.
        Long-term results of in situ subtalar arthrodesis.
        Int Orthop. 2010; 34: 1199-1205
        • Brockmeier SF
        • Shaffer BS.
        Viscosupplementation therapy for osteoarthritis.
        Sports Med Arthrosc Rev. 2006; 14: 155-162
        • Bannuru RR
        • Osani MC
        • Vaysbrot EE
        • Arden NK
        • Bennell K
        • Bierma-Zeinstra SMA
        • Kraus VB
        • Lohmander LS
        • Abbott JH
        • Bhandari M
        • Blanco FJ
        • Espinosa R
        • Haugen IK
        • Lin J
        • Mandl LA
        • Moilanen E
        • Nakamura N
        • Snyder-Mackler L
        • Trojian T
        • Underwood M
        • McAlindon TE.
        OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.
        Osteoarthritis Cartilage. 2019; 27: 1578-1589
        • Bannuru RR
        • Schmid CH
        • Kent DM
        • Vaysbrot EE
        • Wong JB
        • McAlindon TE.
        Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
        Ann Intern Med. 2015; 162: 46-54
        • Schiavi P
        • Calderazzi F
        • Pedrini MF
        • Tacci F
        • Vaienti E
        • Pogliacomi F.
        Efficacy and safety of viscosupplementation with hyaluronic acid for hip osteoarthritis: results from a cross-sectional study with a minimum follow-up of 4 years.
        Acta Biomed. 2020; 91e2020032
        • Xing D
        • Wang B
        • Liu Q
        • Ke Y
        • Xu Y
        • Li Z
        • Lin J.
        Intra-articular hyaluronic acid in treating knee osteoarthritis: a PRISMA-compliant systematic review of overlapping meta-analysis.
        Sci Rep. 2016; 6: 32790
        • Conrozier T
        • Raman R
        • Chevalier X
        • Henrotin Y
        • Monfort J
        • Diraçoglù D
        • Bard H
        • Baron D
        • Jerosch J
        • Richette P
        • Migliore A.
        Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group.
        Ther Adv Musculoskelet Dis. 2021; 28: 1-8
        • Lee GW
        • Kwak WK
        • Lee KB.
        Effects and safety of intra-articular sodium hyaluronate injection for the treatment of ankle osteoarthritis: a prospective clinical trial.
        J Foot Ankle Surg. 2022; 61: 345-349
        • Smith C
        • Patel R
        • Vannabouathong C
        • Sales B
        • Rabinovich A
        • McCormack R
        • Belzile EL
        • Bhandari M.
        Combined intra-articular injection of corticosteroid and hyaluronic acid reduces pain compared to hyaluronic acid alone in the treatment of knee osteoarthritis.
        Knee Surg Sports Traumatol Arthrosc. 2019; 27: 1974-1983
        • Mei-Dan O
        • Carmont M
        • Laver L
        • Mann G
        • Maffulli N
        • Nyska M.
        Intra-articular injections of hyaluronic acid in osteoarthritis of the subtalar joint: a pilot study.
        J Foot Ankle Surg. 2013; 52: 172-176
        • Kohn MD
        • Sassoon AA
        • Fernando ND.
        Classifications in brief: Kellgren-Lawrence classification of osteoarthritis.
        Clin Orthop Relat Res. 2016; 474: 1886-1893
        • Bernetti A
        • Agostini F
        • Alviti F
        • et al.
        New viscoelastic hydrogel hymovis MO.RE. Single intra-articular injection for the treatment of knee osteoarthritis in sportsmen: safety and efficacy study results.
        Front Pharmacol. 2021; 12673988
        • Maheu E
        • Bannuru RR
        • Herrero-Beaumont G
        • Allali F
        • Bard H
        • Migliore A.
        Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: results of an extensive critical literature review.
        Semin Arthritis Rheum. 2019; 48: 563-572
        • Grice J
        • Marsland D
        • Smith G
        • Calder J.
        Efficacy of foot and ankle corticosteroid injections.
        Foot Ankle Int. 2017; 38: 8-13
        • Dasa V
        • DeKoven M
        • Sun K
        • Scott A
        • Lim S.
        Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database.
        Drugs Context. 2016; 5212296
        • Jüni P
        • Hari R
        • Rutjes AW
        • Fischer R
        • Silletta MG
        • Reichenbach S
        • da Costa BR.
        Intra-articular corticosteroid for knee osteoarthritis.
        Cochrane Database Syst Rev. 2015; 2015CD005328
        • Hangody L
        • Szody R
        • Lukasik P
        • Zgadzaj W
        • Lénárt E
        • Dokoupilova E
        • Bichovsk D
        • Berta A
        • Vasarhelyi G
        • Ficzere A
        • Hangody G
        • Stevens G
        • Szendroi M.
        Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (Cingal) to provide symptomatic relief of osteoarthritis of the knee: a randomized, double-blind, placebo-controlled multicenter clinical trial.
        Cartilage. 2018; 9: 276-283
        • Cooper C
        • Rannou F
        • Richette P
        • Bruyère O
        • Al-Daghri N
        • Altman RD
        • Brandi ML
        • Collaud Basset S
        • Herrero-Beaumont G
        • Migliore A
        • Pavelka K
        • Uebelhart D
        • Reginster JY
        Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice.
        Arthritis Care Res (Hoboken). 2017; 69: 1287-1296
        • de Campos GC
        • Rezende MU
        • Pailo AF
        • Frucchi R
        • Camargo OP.
        Adding triamcinolone improves viscosupplementation: a randomized clinical trial.
        Clin Orthop Relat Res. 2013; 471: 613-620
        • Ozturk C
        • Atamaz F
        • Hepguler S
        • Argin M
        • Arkun R.
        The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study.
        Rheumatol Int. 2006; 26: 314-319
        • Petrella RJ
        • Emans PJ
        • Alleyne J
        • Dellaert F
        • Gill DP
        • Maroney M.
        Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
        BMC Musculoskelet Disord. 2015; 16: 57
        • Bowman S
        • Awad ME
        • Hamrick MW
        • Hunter M
        • Fulzele S.
        Recent advances in hyaluronic acid based therapy for osteoarthritis.
        Clin Transl Med. 2018; 7: 6
        • Dasa V
        • DeKoven M
        • Sun K
        • Scott A
        • Lim S.
        Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database.
        Drugs Context. 2016; 5212296
        • Johnston J
        • Brown K
        • Muir J
        • Sloniewsky MJ.
        Long-term outcomes of single versus multiple courses of viscosupplementation for osteoarthritic knee pain: real-world, multi-practice experience over a six-year period.
        J Pain Res. 2021; 14: 2413-2421
        • Witteveen AG
        • Sierevelt IN
        • Blankevoort L
        • Kerkhoffs GM
        • van Dijk CN.
        Intra-articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency.
        Foot Ankle Surg. 2010; 16: 159-163
        • Honvo G
        • Reginster JY
        • Rannou F
        • Rygaert X
        • Geerinck A
        • Rabenda V
        • McAlindon T
        • Charles A
        • Fuggle N
        • Cooper C
        • Curtis E
        • Arden N
        • Avouac B
        • Bruyère O
        Safety of Intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis.
        Drugs Aging. 2019 Apr; 36: 101-127
        • Copay AG
        • Subach BR
        • Glassman SD
        • Polly Jr, DW
        • Schuler TC.
        Understanding the minimum clinically important difference: a review of concepts and methods.
        Spine J. 2007; 7: 541-546
        • Dawson J
        • Boller I
        • Doll H
        • Lavis G
        • Sharp R
        • Cooke P
        • Jenkinson C.
        Minimally important change was estimated for the Manchester-Oxford Foot Questionnaire after foot/ankle surgery.
        J Clin Epidemiol. 2014; 67: 697-705
        • Chan HY
        • Chen JY
        • Zainul-Abidin S
        • Ying H
        • Koo K
        • Rikhraj IS.
        Minimal clinically important differences for American Orthopaedic Foot & Ankle Society score in hallux valgus surgery.
        Foot Ankle Int. 2017; 38: 551-557
        • Sutton RM
        • McDonald EL
        • Shakked RJ
        • Fuchs D
        • Raikin SM.
        Determination of minimum clinically important difference (MCID) in visual analog scale (VAS) Pain and foot and ankle ability measure (FAAM) scores after hallux valgus surgery.
        Foot Ankle Int. 2019; 40: 687-693